Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (64)	6/13/1999 2:48:00 PM
From: Dr. Bob	Read Replies (1) \| Respond to of 226

Mike, You're welcome - I think GLFD and SANG are both great buys still. GLFD has a great deal with AMGN; SANG will be making money big time soon. Fears about government control of drug costs is keeping a lid on this sector for the time being, but when that gets resolved, big drug stocks will flourish, the small companies will be a little further down the road toward profitability, and some major deals will happen - IMO. The ones that will win will be those who have sufficient cash to weather the next two years while their drug candidates are getting approved. Those companies which will need to further dilute their stock at low prices will be in trouble. Bob